Kira Sheinerman

Kira Sheinerman is the Co-Founder and CEO of DiamiR, a privately held molecular diagnostics company focused on developing and commercializing minimally invasive tests for early detection and monitoring of Mild Cognitive Impairment, Alzheimer's disease, and other neurodegenerative and neurological conditions. Prior to DiamiR, Kira was a managing director at Burrill & Company and also served as the Co-Chair of the Alzheimer's Association Business Consortium. Kira has also served on the board of directors for Xenomics Inc.

Kira Sheinerman has a PhD in Biomedical Sciences from Icahn School of Medicine at Mount Sinai and an MBA from Baruch College.

Some individuals on their team include Kenny K. Ablordeppey - Laboratory Supervisor & Project Manager, Gyanendra Kumar - VP, Assay Development, and Vladimir Tsivinsky - Head, Informatics.